These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1670039)

  • 1. Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients.
    Schlich D; L'Heritier C; Coquelin JP; Attali P; Kryrein HJ
    J Int Med Res; 1991; 19(3):271-9. PubMed ID: 1670039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice.
    Maarek L; Cramer P; Attali P; Coquelin JP; Morselli PL
    J Int Med Res; 1992 Apr; 20(2):162-70. PubMed ID: 1521672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
    Shaw SH; Curson H; Coquelin JP
    J Int Med Res; 1992 Apr; 20(2):150-61. PubMed ID: 1521671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice.
    Rosenberg J; Ahlstrøm F
    Scand J Prim Health Care; 1994 Jun; 12(2):88-92. PubMed ID: 7973199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].
    Guazzelli M; Ciapparelli A; Balsamo EL; Gemignani A; Sarteschi P
    Minerva Psichiatr; 1993 Sep; 34(3):193-203. PubMed ID: 8302193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML; McCall WV; Krystal AD; Walsh JK
    J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC; van Balkom AJ; Zitman FG
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):301-6. PubMed ID: 15163440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM; Lee KA; Scharf MB
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N; Hazra A; Das T
    Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
    Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia.
    Tsutsui S;
    J Int Med Res; 2001; 29(3):163-77. PubMed ID: 11471853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD; Perry PJ
    Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem: a review of its use in the management of insomnia.
    Swainston Harrison T; Keating GM
    CNS Drugs; 2005; 19(1):65-89. PubMed ID: 15651908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal rebound insomnia after treatment with 10-mg zolpidem.
    Ware JC; Walsh JK; Scharf MB; Roehrs T; Roth T; Vogel GW
    Clin Neuropharmacol; 1997 Apr; 20(2):116-25. PubMed ID: 9099463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term polysomnographic study of the efficacy and safety of zolpidem in elderly psychiatric in-patients with insomnia.
    Kummer J; Guendel L; Linden J; Eich FX; Attali P; Coquelin JP; Kyrein HJ
    J Int Med Res; 1993; 21(4):171-84. PubMed ID: 8112475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.